Company Valuation: CS Diagnostics Corp.

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025
Market Cap 1 0.3951 150.6 76.47
Change - 38,005.96% -49.21%
Enterprise Value (EV) 1 0.3747 150.6 76.47
Change - 40,076.48% -49.21%
P/E -2,525x 232,000x 1,077x
PBR 0.11x 0.32x 0.15x
PEG - -2,263x 0x
Capitalization / Revenue 3.13x 1,357x 375x
EV / Revenue 2.97x 1,357x 375x
EV / EBITDA - - -
EV / EBIT -17x 197,840x 1,074x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -0.000198 0.000005 0.000284
Distribution rate - - -
Net sales 1 0.126 0.1109 0.204
EBITDA - - -
EBIT 1 -0.022 0.000761 0.0712
Net income 1 -0.022 0.000761 0.0712
Net Debt 1 -0.0204 -0.000501 -0.006813
Reference price 2 0.5000 1.1600 0.3059
Nbr of stocks (in thousands) 790 129,790 249,992
Announcement Date 7/29/25 7/29/25 4/15/26
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 7.25M
30.19x4.1x15.74x2.44% 182B
19.44x3.55x12.69x3.09% 118B
17.7x0.21x12.92x0.74% 61.7B
28.46x7x18.03x1.4% 50.55B
34.65x3.36x11.52x2.18% 48.98B
33.62x5.91x18.54x-.--% 31.65B
43.96x1.28x11.86x0.21% 29.87B
39.29x6.88x24.67x0.27% 23.71B
16.9x2.69x9.55x1.64% 21.78B
Average 29.36x 3.89x 15.06x 1.33% 56.79B
Weighted average by Cap. 27.62x 3.77x 14.73x 1.9%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. CSDX Stock
  4. Valuation CS Diagnostics Corp.
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!